PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29571988-10 2018 MiR-192 and miR-662 inhibition sensitized SCC cells to etoposide but not to cisplatin. Etoposide 55-64 serpin family B member 3 Homo sapiens 42-45 2782919-1 1989 A 69 year-old woman with recurrent uterine cervical cancer was treated by etoposide because of ascites retention and elevated serum SCC level. Etoposide 74-83 serpin family B member 3 Homo sapiens 132-135 16536759-11 2006 CONCLUSIONS: These results indicate that GU SCC is an aggressive cancer; limited-stage SCC of the bladder or prostate, when treated with platinum/etoposide chemotherapy and radical radiotherapy, has a more favourable outcome than that of extensive GU SCC. Etoposide 146-155 serpin family B member 3 Homo sapiens 44-47 23139668-3 2012 We present a case of tonsillar SCC successfully treated with induction chemotherapy using carboplatin and etoposide followed by concurrent chemoradiation therapy with cisplatin as radiosensitizer. Etoposide 106-115 serpin family B member 3 Homo sapiens 31-34 31093350-3 2017 In this report, we present the clinical presentation, diagnosis, and management of a patient with HPV-related SCC of the oropharynx that responded favorably to chemotherapy with cisplatin plus etoposide and concomitant radiation therapy, a regimen typically used in SCLC. Etoposide 193-202 serpin family B member 3 Homo sapiens 110-113 19333541-2 2009 The aim of this study was to evaluate the effectiveness of combination chemotherapy with carboplatin and etoposide (CE) in SCC of the pancreas. Etoposide 105-114 serpin family B member 3 Homo sapiens 123-126 16536759-11 2006 CONCLUSIONS: These results indicate that GU SCC is an aggressive cancer; limited-stage SCC of the bladder or prostate, when treated with platinum/etoposide chemotherapy and radical radiotherapy, has a more favourable outcome than that of extensive GU SCC. Etoposide 146-155 serpin family B member 3 Homo sapiens 87-90 16536759-11 2006 CONCLUSIONS: These results indicate that GU SCC is an aggressive cancer; limited-stage SCC of the bladder or prostate, when treated with platinum/etoposide chemotherapy and radical radiotherapy, has a more favourable outcome than that of extensive GU SCC. Etoposide 146-155 serpin family B member 3 Homo sapiens 87-90 11697847-3 2001 Between 1994 and 1997, three patients with SCC of the esophagus were treated at Besancon University Hospital and this represented 1.85% of all esophageal malignancies diagnosed during this period: one patient had a limited tumor and underwent initial surgical resection, then chemotherapy with cisplatine and etoposide, and radiotherapy for recurrences. Etoposide 309-318 serpin family B member 3 Homo sapiens 43-46 10732775-5 2000 Also, inhibition of the SCC Ag-1 expression in tumour cells by transfection of antisense SCC Ag-1 cDNA was accompanied by significantly increased sensitivity of these cells to apoptosis induced by etoposide or TNF-alpha. Etoposide 197-206 serpin family B member 3 Homo sapiens 24-27 10732775-5 2000 Also, inhibition of the SCC Ag-1 expression in tumour cells by transfection of antisense SCC Ag-1 cDNA was accompanied by significantly increased sensitivity of these cells to apoptosis induced by etoposide or TNF-alpha. Etoposide 197-206 serpin family B member 3 Homo sapiens 89-92 34710250-9 2022 Low doses of etoposide combined with the PARP5B inhibitor XAV939 induced senescence and apoptosis in human SCC lines. Etoposide 13-22 serpin family B member 3 Homo sapiens 107-110